LEV AMINOV

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant MINEOLA, NY NPI 1659680890

General Payments — all program years on this page

$2,304.49

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 71
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $685.08 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $685.0821

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
CSL Behring $470.8111
ABBVIE INC. $123.455
PFIZER INC. $33.872
Janssen Pharmaceuticals, Inc $26.511
E.R. Squibb & Sons, L.L.C. $15.441
Acerta Pharma LLC $15.001

By program year

Program yearAmountRecords
2021 $578.4717
2022 $771.5624
2023 $269.389
2024 $685.0821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078112280 Janssen Pharmaceuticals, Inc $26.51 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101551778 E.R. Squibb & Sons, L.L.C. $15.44 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104316338 AstraZeneca Pharmaceuticals LP $15.00 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106436587 ABBVIE INC. $25.19 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106436589 ABBVIE INC. $27.45 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106436591 ABBVIE INC. $18.43 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106436593 ABBVIE INC. $28.62 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106436595 ABBVIE INC. $23.76 12/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131420902 PFIZER INC. $17.54 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131979592 PFIZER INC. $16.33 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134648919 CSL Behring $33.40 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134648921 CSL Behring $25.31 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134648931 CSL Behring $20.48 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134648937 CSL Behring $29.35 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134648947 CSL Behring $54.70 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134648959 CSL Behring $33.25 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134648965 CSL Behring $30.53 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134649011 CSL Behring $155.00 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134649053 CSL Behring $30.58 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134649055 CSL Behring $33.33 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134649057 CSL Behring $24.88 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.